MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-20-0000894
Manspic Formulation Private Limited
Manspic Formulation Private Limited - pharma in Gwalior, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.38 Cr
▼ 49% YoY
Net profit · FY 2025
₹1.89 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹3.62 Lakh
EBITDA margin 2.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Manspic Formulation Private Limited
Data last updated:
Manspic Formulation Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2012PTC027726. Its GSTIN is 23AAHCM7632A1ZV (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Manish Kumar Lakhotiya and Pooja Lakhotiya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at New Colony No.3A Q.No. 57 Birla Nagar, Gwalior, Madhya Pradesh, India – 474003.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.38 Cr, a decline of 49% compared to the previous year. For the same year it recorded a net profit of ₹1.89 Lakh (net margin 1.4%) and EBITDA of ₹3.62 Lakh (EBITDA margin 2.6%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 10% over five years.
Manspic Formulation Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-20-0000894). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232MP2012PTC027726
Registration Number 027726
Incorporation Date 17 February 2012
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-20-0000894
Recognitions & Rankings of Manspic Formulation
Contact details
Manspic Formulation Private Limited's registered office is in Gwalior, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNew Colony No.3A Q.No. 57 Birla Nagar, Gwalior, Madhya Pradesh, India – 474003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Manspic Formulation Private Limited, buy the company report.
Comprehensive company report
Manspic Formulation Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Manspic Formulation is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Manspic Formulation Private Limited, buy the company report.
Financials of Manspic Formulation Private Limited
FY 2024 filings availableManspic Formulation Private Limited reported revenue of ₹1.38 Cr (down 49% YoY) for FY 2025.
Revenue · FY 2025
₹1.38 Cr ▼ 49%
Net profit · FY 2025
₹1.89 Lakh margin 1.4%
EBITDA · FY 2025
₹3.62 Lakh margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 49%
3 years · compounded
▼ 12%
5 years · compounded
▼ 10%
EBITDA CAGR growth
1 year
▼ 56%
3 years · compounded
▼ 22%
5 years · compounded
▼ 24%
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 49% fall in the latest year. EBITDA fell 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Manspic Formulation Private Limited, buy the company report.
Board of directors of Manspic Formulation Private Limited
Manspic Formulation has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar Lakhotiya Also directs: Kapic Lifesciences (OPC) Private Limited | Director | 08 Nov 2021 | 4 Years 11 Months | Current |
| Pooja Lakhotiya | Director | 16 Jan 2018 | 8 Years 9 Months | Current |
| Chanda Parwal | Director | 13 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Manspic Formulation Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bioglaze Biotech Private Limited | ₹1.38 Cr (FY 2025) | 4.0% | Ambala Cantt, Haryana, India | |||
| Manspic Formulation Private Limitedthis company | ₹1.38 Cr (FY 2025) | ₹1.89 Lakh | 1.4% | -49.0% | Gwalior, Madhya Pradesh, India | |
| Sierra Pharmaceuticals Limited. | ₹1.38 Cr (FY 2024) | -11.0% | New Delhi, Delhi, India | |||
| Dekster Life Sciences Private Limited | ₹1.38 Cr (FY 2025) | 4.0% | Thrissur, Kerala, India | |||
| Ranvin Healthcare Private Limited | ₹1.37 Cr (FY 2025) | 101.0% | Kanpur Nagar, Uttar Pradesh, India | |||
| Adegen Pharma Private Limited | ₹1.37 Cr (FY 2024) | 23.0% | Panchkula, Haryana, India | |||
| Mencure Pharmaceuticals Private Limited | ₹1.37 Cr (FY 2024) | 12.0% | Patna, Bihar, India |
To see the full peer comparison of Manspic Formulation Private Limited, buy the company report.
Auditor
Manspic Formulation Private Limited is audited by DHARMENDRA K. AGARWAL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHARMENDRA K. AGARWAL & CO | FY 2023 | 025525C |
Shareholding
The shareholding of Manspic Formulation Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Manspic Formulation Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Manspic Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Manspic Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Manspic Formulation has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAHCM7632A1ZV | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Manspic Formulation Private Limited, buy the company report.
Recent activity
Manspic Formulation Private Limited has 6 board changes on record since 2018: 3 appointments and 3 cessations. The latest: Manish Kumar Lakhotiya was appointed as Director on 08 Nov 2021.
AGM
Manspic Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Manspic Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Appointed
Manish Kumar Lakhotiya was appointed as Director.
Appointed
Chanda Parwal was appointed as Director.
Ceased
Chandra Kanta Lakhotiya ceased to be Director.
Appointed
Pooja Lakhotiya was appointed as Director.
Ceased
Manish Kumar Lakhotiya ceased to be Director.
Ceased
Santosh Kumar Lakhotia ceased to be Director.
Incorporation
17 Feb 2012
Manspic Formulation Private Limited was registered on 17 Feb 2012 with Roc Gwalior & aged 14 years 8 months as per MCA records.
Frequently asked questions
Manspic Formulation is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 February 2012 (14+ years old) and is registered under CIN U24232MP2012PTC027726.
Manspic Formulation has 3 current directors:
- Manish Kumar Lakhotiya - Director
- Pooja Lakhotiya - Director
- Chanda Parwal - Director
The latest financial statements of Manspic Formulation on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Manspic Formulation is 23AAHCM7632A1ZV, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Manspic Formulation is U24232MP2012PTC027726. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manspic Formulation was incorporated on 17 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Manspic Formulation by revenue are Bioglaze Biotech Private Limited, Sierra Pharmaceuticals Limited, Dekster Life Sciences Private Limited, Ranvin Healthcare Private Limited, Adegen Pharma Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Manish Kumar Lakhotiya was appointed as Director on 08 Nov 2021. Chanda Parwal was appointed as Director on 13 Sep 2021. Chandra Kanta Lakhotiya ceased to be Director on 13 Sep 2021. Manspic Formulation has 6 board changes on record in total.
Yes, Manspic Formulation is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-20-0000894).
The registered office of Manspic Formulation is at New Colony No.3A Q.No. 57 Birla Nagar, Gwalior, Madhya Pradesh, India – 474003.
Manspic Formulation operates in the pharma industry, in the pharmaceutical retailers and distributors segment.